A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

NCT01459250 ·Status: COMPLETED ·Phase: PHASE1

Renal Impairment Study of PF-06700841

NCT04260464 ·Status: COMPLETED ·Phase: PHASE1

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

NCT01442259 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

NCT03241147 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants

NCT04616677 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

NCT06814119 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Renal Impairment Study

NCT00863161 ·Status: COMPLETED ·Phase: PHASE1

Effect of Venglustat in Patients With Renal Impairment

NCT03687554 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

NCT00596518 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004

NCT06742762 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

NCT01738035 ·Status: COMPLETED ·Phase: PHASE2

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

NCT03749447 ·Status: TERMINATED ·Phase: PHASE3

A Study of Fostamatinib in Subjects With Impaired Kidney Function

NCT01245790 ·Status: COMPLETED ·Phase: PHASE1

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

NCT04195919 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

NCT06994897 ·Status: RECRUITING ·Phase: PHASE1

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

NCT02007941 ·Status: COMPLETED ·Phase: PHASE1

A Renal Impairment Study for PF-06651600

NCT04037865 ·Status: TERMINATED ·Phase: PHASE1

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

NCT04699032 ·Status: COMPLETED ·Phase: PHASE1

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

NCT01613690 ·Status: COMPLETED ·Phase: PHASE1

PF-04634817 Renal Impairment Study

NCT01791855 ·Status: COMPLETED ·Phase: PHASE1

NI-0401 in Patients With Acute Renal Allograft Rejection

NCT00805909 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

NCT00984113 ·Status: TERMINATED ·Phase: PHASE1

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

NCT00733265 ·Status: COMPLETED ·Phase: PHASE1